Global Structural Heart Diseases Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Structural Heart Diseases Device market size was valued at US$ 15940 million in 2024 and is forecast to a readjusted size of USD 29460 million by 2031 with a CAGR of 9.3% during review period.

Structural heart devices comprise annuloplasty rings, heart valve balloons occluders among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.

The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart"s structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.

This report is a detailed and comprehensive analysis for global Structural Heart Diseases Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Structural Heart Diseases Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Structural Heart Diseases Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Structural Heart Diseases Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Structural Heart Diseases Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Structural Heart Diseases Device

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Structural Heart Diseases Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Structural Heart Diseases Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
CHD Occluder
Cardioembolic Stroke Occluder
Heart Valve
Other

Market segment by Application
Hospitals
Clinics

Major players covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Structural Heart Diseases Device product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Structural Heart Diseases Device, with price, sales quantity, revenue, and global market share of Structural Heart Diseases Device from 2020 to 2025.

Chapter 3, the Structural Heart Diseases Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Structural Heart Diseases Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Structural Heart Diseases Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Structural Heart Diseases Device.

Chapter 14 and 15, to describe Structural Heart Diseases Device sales channel, distributors, customers, research findings and conclusion.